Baclofen Withdrawal Management

Introduction to Baclofen Withdrawal

Abrupt discontinuation of baclofen can lead to severe withdrawal syndrome, which includes visual and auditory hallucinations, anxiety, agitation, and delirium, fever and tremors, tachycardia and seizures, rebound spasticity and muscle rigidity, and rhabdomyolysis and multiorgan failure (potentially fatal) 1

The severity of withdrawal symptoms correlates with the duration of treatment and dosage, with patients on long-term therapy at highest risk for severe withdrawal symptoms 1

The American College of Physicians recommends a gradual reduction of baclofen dose, with a recommended reduction of 10% of the original dose every 2-4 weeks, slowing to 10% per month when reaching 30% of the original dose, to minimize the risk of withdrawal symptoms 1
A suggested tapering schedule is:

Dose Reduction	Timeframe
10% or less of original dose	initial reduction
10% every 2-4 weeks	subsequent reductions
10% every 2-4 weeks	when reaching 30% of original dose, slow down to this rate

The American College of healthcare providers and the American Academy of Pediatrics recommend adjusting the tapering schedule based on the duration of treatment and individual response, with longer use requiring slower tapering, and if experiencing withdrawal symptoms, to slow down the taper 2, 3

Monitor for withdrawal symptoms during the tapering process, including increased spasticity or muscle tone, fever, altered mental status, tachycardia or hypertension, seizures, and psychomotor agitation, and adjust the tapering protocol as needed 1
If withdrawal symptoms occur during tapering, consider slowing the taper, making smaller reductions, returning to the previous dose, or using adjunctive medications such as benzodiazepines or GABA agonists 1
Regular assessment for signs of withdrawal during the tapering process is crucial, and the tapering schedule should be adjusted based on individual response, with the goal of minimizing withdrawal symptoms 2, 3

For patients on intrathecal baclofen, withdrawal is particularly dangerous and requires specialized management, with a gradual reduction of dose and early involvement of experienced physicians 1
Note that oral baclofen alone may be insufficient to prevent withdrawal in patients previously on intrathecal therapy, and alternative means of baclofen delivery should be considered during weaning 1

Current guidelines often recommend short tapers of 2-4 weeks, which provide minimal benefits over abrupt discontinuation, and may underestimate the risk of withdrawal, highlighting the need for a more gradual tapering protocol 1, 2
Tapering should continue to doses much lower than minimum therapeutic doses to minimize withdrawal symptoms, as suggested by the Mayo Clinic Proceedings 2
The duration of treatment matters, with less than 7 days of use generally allowing for quick discontinuation, 7-14 days of use requiring a more gradual taper, and more than 14 days of use requiring a gradual tapering protocol 3